We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$693M
AUM Growth
-$53.2M
Cap. Flow
+$21.1M
Cap. Flow %
3.04%
Top 10 Hldgs %
46.29%
Holding
382
New
110
Increased
31
Reduced
28
Closed
176

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.7M
3
DIS icon
Walt Disney
DIS
+$14.1M
4
TSM icon
TSMC
TSM
+$6.86M
5
AMZN icon
Amazon
AMZN
+$6.38M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79%
2 Technology 13.91%
3 Communication Services 5.2%
4 Healthcare 1.02%
5 Materials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
26
CALL
EOG Resources
EOG
$77.9B
$7.77M 1.12%
60,000
SPY icon
27
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$7.65M 1.1%
+20,000
New +$7.69M
AAPL icon
28
CALL
Apple
AAPL
$4.86T
$7.6M 1.1%
+58,500
New +$8.36M
NVS icon
29
CALL
Novartis
NVS
$264B
$7.53M 1.09%
+83,000
New +$6.99M
CAT icon
30
PUT
Caterpillar
CAT
$360B
$6.04M 0.87%
+25,200
New +$5.49M
TWLO icon
31
PUT
Twilio
TWLO
$35.6B
$5.53M 0.8%
+113,000
New +$6.43M
IWM icon
32
PUT
iShares Russell 2000 ETF
IWM
$77.6B
$5.23M 0.76%
+30,000
New +$5.34M
FANG icon
33
PUT
Diamondback Energy
FANG
$57.6B
$5.2M 0.75%
38,000
MRTX
34
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.01M 0.72%
110,500
+100,400
+994% +$6.5M
CRSP icon
35
CALL
CRISPR Therapeutics
CRSP
$5.12B
$4.77M 0.69%
+117,400
New +$6.23M
U icon
36
PUT
Unity
U
$19.1B
$4.75M 0.69%
+166,000
New +$5.2M
IP icon
37
CALL
International Paper
IP
$18.1B
$4.66M 0.67%
134,700
-140,000
-51% -$4.84M
IBM icon
38
PUT
IBM
IBM
$235B
$4.23M 0.61%
30,000
BNDD icon
39
PUT
Quadratic Deflation ETF
BNDD
$17.6M
$4.06M 0.59%
+33,750
New +$5.57M
BIIB icon
40
PUT
Biogen
BIIB
$32.1B
$4.02M 0.58%
14,500
-4,500
-24% -$1.27M
LAC
41
CALL
DELISTED
Lithium Americas Corp. Common Shares
LAC
$3.79M 0.55%
+200,000
New +$4.85M
SPB icon
42
CALL
Spectrum Brands
SPB
$1.96B
$3.66M 0.53%
+60,000
New +$3.02M
CAT icon
43
CALL
Caterpillar
CAT
$360B
$3.59M 0.52%
+15,000
New +$3.27M
MDGL icon
44
CALL
Madrigal Pharmaceuticals
MDGL
$12.5B
$3.37M 0.49%
+11,600
New +$1.13M
INDA icon
45
PUT
iShares MSCI India ETF
INDA
$6.57B
$3.34M 0.48%
+80,000
New +$3.39M
FANG icon
46
CALL
Diamondback Energy
FANG
$57.6B
$3.15M 0.45%
23,000
-1,800
-7% -$263K
IBM icon
47
CALL
IBM
IBM
$235B
$2.82M 0.41%
20,000
-15,000
-43% -$2.07M
UTHR icon
48
PUT
United Therapeutics
UTHR
$21.6B
$2.78M 0.4%
+10,000
New +$2.52M
APLS
49
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$2.76M 0.4%
53,400
ATVI
50
PUT
DELISTED
Activision Blizzard
ATVI
$2.6M 0.37%
33,900
+9,700
+40% +$720K

Similar funds

SG3 Management's Q4 2022 Portfolio in Review

As of Q4 2022, SG3 Management held 382 positions worth $693M, down 7.1% from $746M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

SG3 Management deployed $21.1M of net new capital in Q4 2022, opening 110 new positions and adding to 31 existing holdings. Its largest new stake was Alphabet (Google) Class A: 232,500 shares worth $20.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 79% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $32.7M trimmed.

  • SG3 Management's largest Q4 2022 buy was Alphabet (Google) Class A: 232,500 shares worth $20.5M.
  • SG3 Management added most to Microsoft in Q4 2022, an estimated $85.8M increase.
  • SG3 Management's biggest Q4 2022 reduction was Tesla, cutting an estimated $32.7M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $18.7M.
  • SG3 Management's ten largest holdings make up 46% of its $693M portfolio in Q4 2022.
  • SG3 Management opened 110 new positions and closed 176 in Q4 2022.
  • SG3 Management's portfolio value fell 7.1% quarter-over-quarter to $693M.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.